Sep 27, 2021Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access
Sep 9, 2021Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 12, 2021Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result
Aug 5, 2021Anavex Life Sciences to Announce Fiscal 2021 3rd Quarter Financial Results on Thurs., Aug. 12, 2021
May 13, 2021Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook
May 7, 2021Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit
May 6, 2021Anavex Life Sciences to Announce Fiscal 2021 2nd Quarter Financial Results and Business Outlook
Apr 26, 2021Anavex Life Sciences to Present at the B. Riley Securities’ Virtual Neuroscience Conference
Feb 18, 2021Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Jan 11, 2021Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73
Dec 22, 2020Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Dec 21, 2020Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data
Aug 6, 2020Anavex Life Sciences Reports Fiscal 2020 3rd Quarter Financial Results And Provides Business Updates
May 7, 2020Anavex Life Sciences Reports Fiscal 2020 2nd Quarter Financial Results And Provides Business Updates
